These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30936661)

  • 1. Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus.
    Ali A; Safwat M; Kilany WH; Nagy A; Shehata AA; El-Abideen MAZ; Dahshan AM; Arafa AA
    Vet World; 2019 Jan; 12(1):97-105. PubMed ID: 30936661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose of inactivated oil-emulsion bivalent H5N8/H5N1 vaccine protects chickens against the lethal challenge of both highly pathogenic avian influenza viruses.
    Ibrahim M; Zakaria S; Bazid AI; Kilany WH; Zain El-Abideen MA; Ali A
    Comp Immunol Microbiol Infect Dis; 2021 Feb; 74():101601. PubMed ID: 33307456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
    Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
    Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies in the efficacy of H5 inactivated avian influenza vaccines in specific-pathogen-free chickens against challenge with the Egyptian H5N8 clade 2.3.4.4 Group B virus isolated in 2018.
    El-Moeid AA; El-Deeb AH; Elsaied MF; Soliman RA; El-Safty MM; Hussein HA
    Vet World; 2021 Aug; 14(8):2131-2141. PubMed ID: 34566331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA; Awad AM; Sedeik ME
    Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3.4.4 B).
    Maartens LH; Frizzo da Silva L; Dawson S; Love N; Erasmus BJ
    Avian Pathol; 2023 Jun; 52(3):176-184. PubMed ID: 37079321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.
    Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens.
    Oliveira Cavalcanti M; Vaughn E; Capua I; Cattoli G; Terregino C; Harder T; Grund C; Vega C; Robles F; Franco J; Darji A; Arafa AS; Mundt E
    Avian Pathol; 2017 Apr; 46(2):224-233. PubMed ID: 27807985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P
    Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
    Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
    Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.
    Ali ZM; Hassan MAEM; Hussein HA; Ahmed BM; Sanousi AAEE
    Vet World; 2017 Oct; 10(10):1212-1220. PubMed ID: 29184367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.
    Ma J; Lee J; Liu H; Mena I; Davis AS; Sunwoo SY; Lang Y; Duff M; Morozov I; Li Y; Yang J; García-Sastre A; Richt JA; Ma W
    NPJ Vaccines; 2017; 2():33. PubMed ID: 29263888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus of turkey-vectored avian influenza vaccine offers cross-protection against antigenically drifted H5Nx highly pathogenic avian influenza virus strains.
    Nassif S; Zaki F; Mourad A; Fouad E; Saad A; Setta A; Felföldi B; Mató T; Kiss I; Palya V
    Avian Pathol; 2020 Dec; 49(6):547-556. PubMed ID: 32615785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
    Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
    Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.